Evidence map›Paper›PMID 22022856›Full record

ArticleAIDS care2011

Factors related to past HIV testing among South African non-injection drug users.

Lauren R Ropelewski, Alicia Hulbert, William W Latimer

Open access · greenAbstract read
In one paragraph

Article in AIDS care, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lauren R RopelewskiDepartment of Mental Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. lropelew@jhsph.edu
Alicia Hulbert
William W Latimer
Johns Hopkins University · US

Funding

NIDA Epidemiology Training Program: Johns Hopkins UniversityT32DA007292 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RENEE M. JOHNSON, Brion S Maher · 1993 to 2026
$17.7M
Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug UsersR01DA014498 · NIDA · UNIVERSITY OF FLORIDA · PI LATIMER, WILLIAM W · 2001 to 2013
$5.6M
Drug Dependence Epidemiology and EnviromicsK05DA015799 · NIDA · MICHIGAN STATE UNIVERSITY · PI ANTHONY, JAMES CHRISTOPHER · 2003 to 2015
$1.4M
NIDA NIH HHS K05 DA015799NIDA NIH HHS R01 DA014498NIDA NIH HHS R01DA014498NIDA NIH HHS T32 DA007292NIDA NIH HHS T32DA007292
6 · The paper itself

Abstract

South Africa has some of the highest estimates of human immunodeficiency virus (HIV) in the world, with a prevalence of 21.5%. Despite this, based on population-level data, 39% of sexually active South Africans have never been tested for HIV. Non-injection drug users (NIDUs) are a high-risk and increasingly prevalent group in South Africa. However, few studies have examined HIV test utilization among high-risk groups such as drug users in South Africa. The study was conducted in Pretoria, South Africa between 2002 and 2006. Of the 382 individuals surveyed, 31% had been tested for HIV in the past. Results indicate that females and older individuals were significantly more likely to have been tested for HIV at some point in the past, while individuals who did not know someone with HIV/AIDS as well as individuals who are unsure of their risk of HIV infection were significantly less likely to have ever accessed testing. Identification of these subgroups has implications for the development of targeted interventions to promote greater HIV testing among at-risk groups in South Africa.

Indexed as

Health Knowledge, Attitudes, PracticeHIV InfectionsAdultDrug UsersFemaleHumansMaleRisk FactorsRisk-TakingSouth AfricaSubstance-Related DisordersYoung Adult

Identifiers

PMID22022856
PMCPMC3205418
OpenAlexW1986026567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.